Elderly Esophageal Cancer Patients Receive Suboptimal Therapy by Angela Mohan on February 10, 2021 at 2:25 PM
Patients aged above 70 years with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer should be provided with optimal therapy that has the potential to cure, which includes initial chemoradiotherapy (NACR) and surgical resection.
According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen.
In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old).
Journal of the American College of Surgeons in advance of print.
Date Time
Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks
Older patients who do receive recommended multimodal therapy, including surgery, have outcomes comparable with those of younger patients
CHICAGO: Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ.
According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen. In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old). The single-institution study from the Ochsner Clinic
The Ochsner Clinic Foundation filed advance notices with Louisiana Economic Development regarding plans to expand several of its facilities across the state, including two in Baton Rouge.